I agree that this site is using cookies. You can find further informations here.
X
Pfister, Sophia Xiao
78  results:
Search for persons X
?
1

EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Effic..:

Stairiker, Christopher J. ; Pfister, Sophia Xiao ; Hendrickson, Eleanore...
Frontiers in Immunology.  12 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Combinatorial immunotherapy induces tumor-infiltrating CD8+..:

Van Braeckel-Budimir, Natalija ; Dolina, Joseph Samuel ; Wei, Jie...
Journal for ImmunoTherapy of Cancer.  9 (2021)  12 - p. e003614 , 2021
Link: https://doi.org/10.1136/..
 
?
3

EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Effic..:

Christopher J. Stairiker ; Sophia Xiao Pfister ; Eleanore Hendrickson...
https://www.frontiersin.org/articles/10.3389/fimmu.2021.770080/full.  , 2021
Link: https://doi.org/10.3389/..
 
?
4

DataSheet_1_EZH2 Inhibition Compromises α4-1BB-Mediated Ant..:

Christopher J. Stairiker ; Sophia Xiao Pfister ; Eleanore Hendrickson...
doi:10.3389/fimmu.2021.770080.s001.  , 2021
Link: https://doi.org/10.3389/..
 
?
5

DataSheet_1_EZH2 Inhibition Compromises α4-1BB-Mediated Ant..:

Christopher J. Stairiker (8281698) ; Sophia Xiao Pfister (11789474) ; Eleanore Hendrickson (11749802)...
https://figshare.com/articles/dataset/DataSheet_1_EZH2_Inhibition_Compromises_4-1BB-Mediated_Antitumor_Efficacy_by_Reducing_the_Survival_and_Effector_Programming_of_CD8_T_Cells_pdf/17121521.  , 2021
Link: https://doi.org/10.3389/..
 
?
6

Combinatorial immunotherapy induces tumor-infiltrating CD8(..:

Van Braeckel-Budimir, Natalija ; Dolina, Joseph Samuel ; Wei, Jie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672007/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concur..:

Dunn, Lara A. ; Riaz, Nadeem ; Fury, Matthew G....
International Journal of Radiation Oncology*Biology*Physics.  106 (2020)  3 - p. 564-570 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Phase II trial of bevacizumab + cetuximab + cisplatin with ..:

Fury, Matthew G. ; Xiao, Han ; Sherman, Eric J....
Head & Neck.  38 (2015)  S1 - p. , 2015
Link: https://doi.org/10.1002/..
 
?
9

A phase II study of pralatrexate with vitamin B12 and folic..:

Ho, Alan L. ; Lipson, Brynna L. ; Sherman, Eric J....
Investigational New Drugs.  32 (2014)  3 - p. 549-554 , 2014
Link: https://doi.org/10.1007/..
 
?
10

A phase 1 study of everolimus plus docetaxel plus cisplatin..:

Fury, Matthew G. ; Sherman, Eric ; Ho, Alan L....
Cancer.  119 (2013)  10 - p. 1823-1831 , 2013
Link: https://doi.org/10.1002/..
 
?
11

Divergent clonal selection dominates medulloblastoma at rec..:

Morrissy, A. Sorana ; Garzia, Livia ; Shih, David J. H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936195/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
12

A Phase II Trial of Bevacizumab + Cetuximab + Cisplatin wit..:

Fury, Matthew G ; Xiao, Han ; Sherman, Eric J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398410/.  , 2015
Link: http://www.ncbi.nlm.nih...
 
?
13

A Phase 1 Study of Everolimus Plus Docetaxel Plus Cisplatin..:

Matthew G., Fury ; Sherman, Eric ; Ho, Alan L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969235.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
14

A Randomized Phase II Study of Cetuximab Every 2 Weeks at E..:

Fury, Matthew G ; Sherman, Eric ; Lisa, Donna...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726232/.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
15

From weakness comes strength:

Pfister, Sophia X.
Science.  377 (2022)  6604 - p. 442-442 , 2022
Link: https://doi.org/10.1126/..
 
1-15